Physician profile
Tracy Puza
NPI 1245452200
$1,847.78
in general payments reported to CMS, 2019-2025
17 companies · $894 in 2025
The $894 reported for 2025 was more than what 88% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $953 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,847.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $573.50 | 2024-2025 | Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $536.51 | 2024-2025 | Relistor |
| Biotronik Nro, INC. | $203.03 | 2024-2025 | Prospera |
| Scilex Pharmaceuticals INC. | $148.69 | 2024-2025 | |
| Azurity Pharmaceuticals, INC. | $84.92 | 2024-2025 | Horizant |
| Novartis Pharmaceuticals Corporation | $44.08 | 2024-2025 | |
| Merz Pharmaceuticals, LLC | $37.47 | 2025 | Xeomin |
| Sobi, INC | $31.95 | 2024 | |
| Medtronic, INC. | $31.56 | 2024 | Intellis Adaptivestim |
| Protega Pharmaceutials INC | $28.19 | 2024 | Roxybond |
| Spinal Simplicity, LLC | $23.30 | 2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $21.25 | 2025 | Wavewriter Alpha Prime 16 |
| Karyopharm Therapeutics INC. | $20.31 | 2024 | Xpovio |
| Janssen Biotech, INC. | $19.28 | 2024 | Rybrevant |
| Acrotech Biopharma INC. | $16.60 | 2025 | Beleodaq |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $14.00 | 2024 | Genvisc 850 Sodium Hyaluronate |
| Ibsa Pharma INC. | $13.14 | 2024 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Puza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.